Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2022Molecular MedicineOpen Access

Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

HLHongzhi LiBSBohao SunYHYuting Huang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2022) studied this question.

synapsesocial.com/papers/6aa9205086badb2eb40dfdfchttps://doi.org/10.1186/s10020-022-00456-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate Brain2009 · 132 citations
  2. 2Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression2013 · 423 citations
  3. 3Reduction of Infarct Size by the Therapeutic Protein TAT-Ndi1 In Vivo2013 · 19 citations
  4. 4Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti‐Her2 chimeric antigen receptor gene2018 · 25 citations
  5. 5Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases2019 · 50 citations